Cell Reports – 2019 Jun 18 – PMID: 31216465
Marcar L, Bardhan K, Gheorghiu L, Dinkelborg P, Pfäffle H, Liu Q, Wang M, Piotrowska Z, Sequist LV, Borgmann K, Settleman JE, Engelman JA, Hata AN*, Willers H*. Acquired resistance of EGFR-mutated lung cancer to tyrosine kinase inhibitor treatment promotes PARP inhibitor sensitivity. Cell Reports. 2019 Jun 18;27(12):3422-3432. PMID: 31216465
